304 related articles for article (PubMed ID: 29134827)
41. Circulating Tumor DNA in Saliva in an Orthotopic Head and Neck Cancer Mouse Model.
Eun YG; Yoon YJ; Won KY; Lee YC
Anticancer Res; 2020 Jan; 40(1):191-199. PubMed ID: 31892567
[TBL] [Abstract][Full Text] [Related]
42. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy.
Rapado-González Ó; López-López R; López-Cedrún JL; Triana-Martínez G; Muinelo-Romay L; Suárez-Cunqueiro MM
Cells; 2019 Dec; 8(12):. PubMed ID: 31861130
[TBL] [Abstract][Full Text] [Related]
43. Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.
Skinner HD; Giri U; Yang L; Woo SH; Story MD; Pickering CR; Byers LA; Williams MD; El-Naggar A; Wang J; Diao L; Shen L; Fan YH; Molkentine DP; Beadle BM; Meyn RE; Myers JN; Heymach JV
Clin Cancer Res; 2016 Sep; 22(18):4643-50. PubMed ID: 27036135
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.
Shaikh MH; Khan AI; Sadat A; Chowdhury AH; Jinnah SA; Gopalan V; Lam AK; Clarke DTW; McMillan NAJ; Johnson NW
BMC Cancer; 2017 Nov; 17(1):792. PubMed ID: 29178862
[TBL] [Abstract][Full Text] [Related]
45. Role of salivary miRNAs as noninvasive biomarkers in head and neck squamous cell carcinomas and oral potentially malignant disorders - Reply.
Zhu L; Li M; Tang G; Shi L; Liu W
Oral Oncol; 2022 Dec; 135():106224. PubMed ID: 36323070
[No Abstract] [Full Text] [Related]
46. The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities.
Zaporozhchenko IA; Ponomaryova AA; Rykova EY; Laktionov PP
Expert Rev Mol Diagn; 2018 Feb; 18(2):133-145. PubMed ID: 29307231
[TBL] [Abstract][Full Text] [Related]
47. A liquid biopsy for head and neck cancers.
Schmidt H; Kulasinghe A; Perry C; Nelson C; Punyadeera C
Expert Rev Mol Diagn; 2016; 16(2):165-72. PubMed ID: 26631411
[TBL] [Abstract][Full Text] [Related]
48. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma?
Thomas J; Primeaux T
Ann Diagn Pathol; 2012 Apr; 16(2):91-9. PubMed ID: 22197546
[TBL] [Abstract][Full Text] [Related]
49. A computational method for prediction of saliva-secretory proteins and its application to identification of head and neck cancer biomarkers for salivary diagnosis.
Sun Y; Du W; Zhou C; Zhou Y; Cao Z; Tian Y; Wang Y
IEEE Trans Nanobioscience; 2015 Mar; 14(2):167-74. PubMed ID: 25675464
[TBL] [Abstract][Full Text] [Related]
50. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
[TBL] [Abstract][Full Text] [Related]
51. Isolation of salivary cell-free DNA for cancer detection.
Brooks PJ; Malkin EZ; De Michino S; Bratman SV
PLoS One; 2023; 18(5):e0285214. PubMed ID: 37130100
[TBL] [Abstract][Full Text] [Related]
52. High NOTCH1 mRNA Expression Is Associated with Better Survival in HNSCC.
Wirth M; Jira D; Ott A; Piontek G; Pickhard A
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29533972
[TBL] [Abstract][Full Text] [Related]
53. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.
Solomon B; Young RJ; Rischin D
Semin Cancer Biol; 2018 Oct; 52(Pt 2):228-240. PubMed ID: 29355614
[TBL] [Abstract][Full Text] [Related]
54. Salivary soluble CD44: a potential molecular marker for head and neck cancer.
Franzmann EJ; Reategui EP; Carraway KL; Hamilton KL; Weed DT; Goodwin WJ
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):735-9. PubMed ID: 15767360
[TBL] [Abstract][Full Text] [Related]
55. Salivary and serum proteomics in head and neck carcinomas: before and after surgery and radiotherapy.
Vidotto A; Henrique T; Raposo LS; Maniglia JV; Tajara EH
Cancer Biomark; 2010-2011; 8(2):95-107. PubMed ID: 21896997
[TBL] [Abstract][Full Text] [Related]
56. [Exosomes: potential liquid biopsy in head and neck cancer].
Theodoraki MN; Ludwig S
HNO; 2020 Feb; 68(2):106-110. PubMed ID: 31915880
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting.
Economopoulou P; de Bree R; Kotsantis I; Psyrri A
Front Oncol; 2019; 9():827. PubMed ID: 31555588
[TBL] [Abstract][Full Text] [Related]
58. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
Sano D; Oridate N
Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
[TBL] [Abstract][Full Text] [Related]
59. mRNA, microRNA and lncRNA as novel bladder tumor markers.
Wieczorek E; Reszka E
Clin Chim Acta; 2018 Feb; 477():141-153. PubMed ID: 29224950
[TBL] [Abstract][Full Text] [Related]
60. Liquid Biopsy in Neurological Diseases.
Malhotra S; Miras MCM; Pappolla A; Montalban X; Comabella M
Cells; 2023 Jul; 12(14):. PubMed ID: 37508574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
